Reimbursement
One tracks the effectiveness of COVID-19 drug therapies and the other pays for counseling to slow the spread of the virus.
The order reinstates a previously withdrawn rule mandating PBMs to give the rebate savings to consumers, rather than health plans.
A number of high-yield healthcare issuers have defaulted since the start of the crisis, and near-term credit risk remains elevated.
In March there was a 35% decrease in weekly hospitalizations and a 45% decrease in weekly hospitalizations not related to COVID-19.
Even upticks in COVID-19 patients haven't made up for the revenue losses, since reimbursement for those services is comparatively slim.
Hospital margins could sink to a median as low as -7% by year's end, and half of all hospitals may be in the red.
The plans do not comply with the comprehensive benefits of the Affordable Care Act.
The loss of hospital revenue due to the ruling is estimated at $800 million for 2020.
Halvorson envisions an integrated system which unites healthcare payment, improvement and racial and economic equity.
Demand for physicians, as gauged by the number of new search engagements, has declined by over 30% since March 21.